63 related articles for article (PubMed ID: 11602655)
1. Characterization of novel kidney-specific delivery system using an alkylglucoside vector.
Shirota K; Kato Y; Suzuki K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Nov; 299(2):459-67. PubMed ID: 11602655
[TBL] [Abstract][Full Text] [Related]
2. Renal drug targeting using a vector "alkylglycoside".
Suzuki K; Susaki H; Okuno S; Sugiyama Y
J Pharmacol Exp Ther; 1999 Jan; 288(1):57-64. PubMed ID: 9862753
[TBL] [Abstract][Full Text] [Related]
3. Detection of the membrane protein recognized by the kidney-specific alkylglucoside vector.
Watanabe Y; Suzuki H; Suzuki K; Ando T; Nakabayashi S; Sugiyama Y
Pharm Res; 2000 Jan; 17(1):49-54. PubMed ID: 10714608
[TBL] [Abstract][Full Text] [Related]
4. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
5. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines.
Ekrami HM; Shen WC
J Drug Target; 1995; 2(6):469-75. PubMed ID: 7773608
[TBL] [Abstract][Full Text] [Related]
6. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
7. Specific renal delivery of sugar-modified low-molecular-weight peptides.
Suzuki K; Susaki H; Okuno S; Yamada H; Watanabe HK; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):888-97. PubMed ID: 9918603
[TBL] [Abstract][Full Text] [Related]
8. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification.
Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A
Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045
[TBL] [Abstract][Full Text] [Related]
9. Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone).
Somogyi G; Buchwald P; Bodor N
Pharmazie; 2002 Feb; 57(2):135-7. PubMed ID: 11878190
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
Kaminskas LM; Kelly BD; McLeod VM; Boyd BJ; Krippner GY; Williams ED; Porter CJ
Mol Pharm; 2009; 6(4):1190-204. PubMed ID: 19453158
[TBL] [Abstract][Full Text] [Related]
11. Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier.
Yamamoto Y; Tsutsumi Y; Yoshioka Y; Kamada H; Sato-Kamada K; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
J Control Release; 2004 Mar; 95(2):229-37. PubMed ID: 14980771
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
13. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin.
Johnston TP; Kuchimanchi KR; Alur H; Chittchang M; Mitra AK
J Pharm Pharmacol; 2003 Aug; 55(8):1083-90. PubMed ID: 12956897
[TBL] [Abstract][Full Text] [Related]
14. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
[TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
17. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
[TBL] [Abstract][Full Text] [Related]
18. Ability of a small, basic protein isolated from Russell's viper venom (Daboia russelli russelli) to induce renal tubular necrosis in mice.
Mandal S; Bhattacharyya D
Toxicon; 2007 Aug; 50(2):236-50. PubMed ID: 17499831
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography.
Li D; Wang Q; Yuan ZF; Zhang L; Xu L; Cui Y; Duan K
J Pharm Biomed Anal; 2008 Jun; 47(2):429-34. PubMed ID: 18395390
[TBL] [Abstract][Full Text] [Related]
20. IONP-PLL: a novel non-viral vector for efficient gene delivery.
Xiang JJ; Tang JQ; Zhu SG; Nie XM; Lu HB; Shen SR; Li XL; Tang K; Zhou M; Li GY
J Gene Med; 2003 Sep; 5(9):803-17. PubMed ID: 12950071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
